Inside informationEnglish
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 21/01/2026, 18:02
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110456_20260121